Researchers have made a breakthrough in more precisely targeting drugs to cancers. A number of Centre members were part of a multi-disciplinary team of biomedical engineers, oncologists, radiologists and anaesthetists that have used ultrasound and lipid drug carriers (liposomes) to improve the targeting of cancer drugs to a tumour. The new technology has been used […]
About Oxford Centre
This author has yet to write their bio.Meanwhile lets just say that we are proud Oxford Centre contributed a whooping 72 entries.
Entries by Oxford Centre
In a collaboration spanning multiple departments within Oxford and beyond, Centre members led by Dr Ioannis Psallidas have developed a new risk score (PROMISE score) that can provide important information on patient prognosis, and guide the selection of appropriate management strategies for patients with malignant pleural effusion. Malignant pleural effusion is defined as the accumulation […]
Results of the AspECT clinical trial, coordinated by the CRUK Oxford Centre supported Oncology Clinical Trials Office, have shown the important role aspirin and acid reflux treatment can have in preventing those at high risk of oesophageal cancer from going on to develop the disease. The trial led by Professor Janusz Jankowski had results presented […]
New initiative with the Synthetic Biology CDT
The Centre is pleased to announce the appointment of Professor Xin Lu as Co-Director of the Centre.
Today at the NCRI Annual Conference Professor Simon Leedham was awarded the Cancer Research UK Future Leaders in Cancer Research Prize. Simon is a Cancer Research UK Clinician Scientist Fellow at the Wellcome Trust Centre for Human Genetics. His research has made important advances in the cell biology and molecular pathogenesis of gastrointestinal cancers and […]
Professor Nicola Sibson of the Department of Oncology has been awarded a grant worth almost £200,000 by research charity Breast Cancer Now to fund cutting-edge research to uncover novel treatment combinations to control breast cancer that has spread to the brain.
John Findlay wins Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS) prize for his presentation ’Staging gastric cancer with 18F-FDG PET-CT identifies frequent unsuspected metastases and patients of high risk of incurable disease, early recurrence and death’
Today a new drug will become available for patients with bowel cancer as part of a national clinical trial; based on a scientific discovery made only two years ago at the University of Oxford.
Professor Tim Maughan, Professor of Clinical Oncology at the University of Oxford and Principal Lead of the S:CORT Consortium said: “This research emphasises how a collaborative approach can give significant insight into bowel cancer disease biology, but also to begin to translate this knowledge into clinically-relevant applications. As part of the work of the S:CORT consortium, we will now focus on making sure that the research is put into practice so that it can become part of the standard of care for patients.”
- Focussed ultrasound and nanomedicine offer new hope for improving effects of cancer drugsJuly 10, 2018 - 8:05 am
- Prognostic biomarkers discovered for patients with malignant pleural effusionJune 29, 2018 - 9:36 am
- Aspirin and acid reflux medication reduce the likelihood of patients with Barrett’s oesophagus developing oesophageal cancer.June 12, 2018 - 3:53 pm